FDA.reportPublic FDA data

18 ML aprepitant 7.2 MG/ML Injection

RxCUI
1995150
RxNorm name
18 ML aprepitant 7.2 MG/ML Injection
Display name
18 ML aprepitant 7.2 MG/ML Injection
Full name
18 ML aprepitant 7.2 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CINVANTIAPREPITANTHeron Therapeutics, Inc.4c218d3a-a508-4abc-9ed8-a6e8e191d1b42026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1995150

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c218d3a-a508-4abc-9ed8-a6e8e191d1b4aprepitant 130 MG in 18 ML Injection [PSN] · 18 ML aprepitant 7.2 MG/ML Injection [SCD] · aprepitant 130 MG per 18 ML Injection [SY]315These highlights do not include all the information needed to use CINVANTI ® safely and effectively. See full prescribing information for CINVANTI. CINVANTI ® (aprepitant) injectable emulsion, for intravenous use Initial U.S. Approval: 200320260401